Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Brain Injury Global Clinical Trials Review, H1

Brain Injury Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Brain Injury Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Brain Injury Global Clinical Trials Review, H1, 2015" provides an overview of Brain Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Brain Injury 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Brain Injury to Central Nervous System Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Brain Injury to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Brain Injury 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Brain Injury Therapeutics Clinical Trials 31

Prominent Drugs 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Pfizer Inc. 33

Clinical Trial Overview of Pfizer Inc. 33

ZonMw 34

Clinical Trial Overview of ZonMw 34

Novo A/S 35

Clinical Trial Overview of Novo A/S 35

Cato Research Ltd. 36

Clinical Trial Overview of Cato Research Ltd. 36

Canbex Therapeutics Ltd. 37

Clinical Trial Overview of Canbex Therapeutics Ltd. 37

AstraZeneca Plc 38

Clinical Trial Overview of AstraZeneca Plc 38

Astellas Pharma Inc. 39

Clinical Trial Overview of Astellas Pharma Inc. 39

AmKor Pharma, Inc. 40

Clinical Trial Overview of AmKor Pharma, Inc. 40

Alexander David Investments PLC (Inactive) 41

Clinical Trial Overview of Alexander David Investments PLC (Inactive) 41

Actavis Plc 42

Clinical Trial Overview of Actavis Plc 42

Clinical Trial Overview of Top Institutes / Government 43

Vanderbilt University 43

Clinical Trial Overview of Vanderbilt University 43

ALYN Pediatric and Adolescent Rehabilitation Center 44

Clinical Trial Overview of ALYN Pediatric and Adolescent Rehabilitation Center 44

Eunice Kennedy Shriver National Institute of Child Health and Human Development 45

Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 45

Shaanxi Provincial People's Hospital 46

Clinical Trial Overview of Shaanxi Provincial People's Hospital 46

Tabriz University of Medical Sciences 47

Clinical Trial Overview of Tabriz University of Medical Sciences 47

University of Nottingham 48

Clinical Trial Overview of University of Nottingham 48

Assistance Publique-Hopitaux de Paris 49

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 49

Associacao de Assistencia a Crianca Deficiente 50

Clinical Trial Overview of Associacao de Assistencia a Crianca Deficiente 50

Atlantic Health System 51

Clinical Trial Overview of Atlantic Health System 51

Baycrest 52

Clinical Trial Overview of Baycrest 52

Five Key Clinical Profiles 53

Appendix 84

Abbreviations 84

Definitions 84

Research Methodology 85

Secondary Research 85

About GlobalData 86

Contact Us 86

Disclaimer 86

Source 87

List of Figures

Brain Injury Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Brain Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Brain Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Brain Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Brain Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Brain Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Brain Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Brain Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Brain Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Brain Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Brain Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Brain Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Brain Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Brain Injury Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Brain Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Brain Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Brain Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Brain Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Brain Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Brain Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Brain Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Brain Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 85

List of Tables

Brain Injury Therapeutics, Global, Clinical Trials by Region, 2015* 7

Brain Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Brain Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Brain Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Brain Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Brain Injury Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Brain Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Brain Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Brain Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Brain Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Brain Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Brain Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Brain Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Brain Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Brain Injury Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Brain Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Brain Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Brain Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Brain Injury Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Brain Injury Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Brain Injury Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Brain Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Brain Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Brain Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Brain Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Brain Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2015* 34

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 35

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Cato Research Ltd., 2015* 36

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Canbex Therapeutics Ltd., 2015* 37

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 38

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 39

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AmKor Pharma, Inc., 2015* 40

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexander David Investments PLC (Inactive), 2015* 41

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis Plc, 2015* 42

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 43

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by ALYN Pediatric and Adolescent Rehabilitation Center, 2015* 44

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 45

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaanxi Provincial People's Hospital, 2015* 46

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015* 47

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nottingham, 2015* 48

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 49

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Associacao de Assistencia a Crianca Deficiente, 2015* 50

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Atlantic Health System, 2015* 51

Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Baycrest, 2015* 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Pfizer Inc.

ZonMw

Novo A/S

Cato Research Ltd.

Canbex Therapeutics Ltd.

AstraZeneca Plc

Astellas Pharma Inc.

AmKor Pharma, Inc.

Actavis Plc

Brain Injury Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Brain Injury, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com